Innovative Drug Synthesis

Zusatztext

This book covers all aspects of the medicinal chemistry of the latest drugs, and the cutting-edge science associated with them. Following the editors 3 successful drug synthesis books, this provides expert analysis of the pros and cons of different synthetic routes and demystifies the process of modern drug discovery for practitioners and researchers.<br /><br /><ul><li>Summarizes for each drug: respective disease area, important properties and SAR (structure-activity relationship), and chemical synthesis routes / options</li><li>Includes case studies in each chapter</li><li>Illustrates how chemistry, biology, pharmacokinetics, and a host of disciplines come together to produce successful medicines</li><li>Explains the advantages of process synthesis versus the synthetic route for drug discovery</li></ul>

Autorenportrait

<p><b>Jie Jack Li</b> is an Associate Professor of chemistry at the University of San Francisco. Previously, he was a Discovery Chemist at Bristol-Myers Squibb and Pfizer. He has authored or edited over 20 books and several of those were published by Wiley, including<i>Drug Discovery: Practices, Processes, and Perspectives, Heterocyclic Chemistry in Drug Discovery, Name Reactions in Heterocyclic Chemistry, Name Reactions for Functional Group Transformations, Contemporary Drug Synthesis, The Art of Drug Synthesis, and Modern Drug Synthesis</i><p><b>Douglas S. Johnson</b> is a Research Fellow and Head of Chemical Biology in the Neuroscience Medicinal Chemistry group at Pfizer Worldwide Research and Development. He is a co-author on more than 75 publications and patents and is a co-author of the book<i>Contemporary Drug Synthesis and is an editor of The Art of Drug Synthesis, and Modern Drug Synthesis</i> (all published by Wiley).

Weitere Details